BIO-key International Inc. (NASDAQ:BKYI – Get Free Report) was the recipient of a significant decline in short interest during the month of September. As of September 15th, there was short interest totaling 6,628 shares, a decline of 39.1% from the August 31st total of 10,889 shares. Currently, 0.5% of the shares of the stock are short sold. Based on an average daily volume of 12,544 shares, the days-to-cover ratio is currently 0.5 days.
BIO-key International Price Performance
BKYI stock opened at $2.12 on Friday. The company’s 50 day simple moving average is $3.11 and its 200-day simple moving average is $4.34. BIO-key International has a 12 month low of $1.63 and a 12 month high of $19.70. The firm has a market capitalization of $3.04 million, a PE ratio of -0.52 and a beta of 0.50.
BIO-key International (NASDAQ:BKYI – Get Free Report) last issued its quarterly earnings data on Thursday, August 13th. The technology company reported ($0.56) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.82) by $0.26. The firm had revenue of $1.92 million during the quarter, compared to the consensus estimate of $1.80 million. BIO-key International had a negative return on equity of 67.31% and a negative net margin of 50.01%. As a group, sell-side analysts anticipate that BIO-key International will post -1.62 earnings per share for the current year.
Analysts Set New Price Targets
Read Our Latest Analysis on BKYI
About BIO-key International
BIO-key International, Inc develops biometric identity and access management solutions designed to help organizations secure applications, devices and networks. Its offerings use fingerprint authentication and other authentication methods to provide alternatives or supplements to passwords, supporting secure access for employees, students, customers and other users.
The company’s products include biometric readers and related software, as well as its PortalGuard identity and access management platform.
See Also
- Five stocks we like better than BIO-key International
- AST SpaceMobile’s BlueBird Progress Comes With Several Risks Still Unresolved
- Time to Nibble on MCD Stock After it Enters Oversold Territory?
- McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal Upside
- Corning and AT&T’s $3 Billion Fiber Deal Reveals Where AI Spending Goes Next
Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.
